Predictive biomarkers of ipilimumab toxicity in metastatic melanoma.

被引：2
|
作者：
Gowen, Michael
Tchack, Jeremy
Zhou, Hua
Giles, Keith Michael
Paschke, Scott
Moran, Una
Fenyo, David
Tsirigos, Aristotelis
Pacold, Michael
Pavlick, Anna C.
Krogsgaard, Michelle
Osman, Iman
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.9559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9559
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Identification of predictive biomarkers for dasatinib treatment of metastatic melanoma.
    Eustace, A. J.
    Kennedy, S.
    Larkin, A.
    Mahgoub, T.
    Tryfonopoulos, D.
    O'Driscoll, L.
    Clynes, M.
    Crown, J.
    O'Donovan, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] Ipilimumab plus temozolomide in metastatic melanoma.
    Patel, S. P.
    Bedikian, A. Y.
    Papadopoulos, N. E.
    Hwu, W.
    Kim, K. B.
    Homsi, J.
    Davies, M. A.
    Woodman, S. E.
    Radvanyi, L. G.
    Woodard, K.
    Mahoney, S.
    Hwu, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Metastatic malignant melanoma. Successfull treatment with ipilimumab
    Jansen, T.
    Bruch-Gerharz, D.
    Reifenberger, J.
    Schulte, K. W.
    [J]. HAUTARZT, 2013, 64 (04): : 228 - +
  • [4] Retrospective analysis of retreatment with Ipilimumab in patients with metastatic melanoma.
    Formozo, Andre Alexandre
    Gomes, Jessica Ribeiro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Predictive biomarkers of check point inhibition toxicity in metastatic melanoma
    Gowen, Mike
    Tchack, Jeremy
    Zhou, Hua
    Giles, Keith
    Paschke, Scott
    Moran, Una
    Fenyo, David
    Tsirigos, Aris
    Pacold, Michael
    Pavlick, Anna
    Krogsgaard, Michelle
    Osman, Iman
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [6] Novel Predictive Biomarkers in Melanoma Treatment with Ipilimumab
    Gebhardt, C.
    Sevko, A.
    Jiang, H.
    Lichtenberger, R.
    Reith, M.
    Tarnanidis, K.
    Umansky, L.
    Beckhove, P.
    Sucker, A.
    Schadendorf, D.
    Utikal, J.
    Umansky, V.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 6 - 6
  • [7] Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
    Nyakas, M.
    Aamdal, E.
    Jacobsen, K. D.
    Guren, T. K.
    Aamdal, S.
    Hagene, K. T.
    Brunsvig, P.
    Yndestad, A.
    Halvorsen, B.
    Tasken, K. A.
    Aukrust, P.
    Maelandsmo, G. M.
    Ueland, T.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 197 (01): : 74 - 82
  • [8] Diarrhea from Ipilimumab in Melanoma.
    Schwartz, Jonathan D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2262 - 2262
  • [9] Use of ipilimumab in patients with metastatic melanoma. Experience at the Medica Sur Hospital
    Manuel Ruiz-Morales, Jose
    Rafael Rodriguez-Cid, Jeronimo
    Alvarado-Luna, Gabriela
    Green-Renner, Dan
    Motola-Kuba, Daniel
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (03): : 157 - 161
  • [10] Dose-dependent toxicity of ipilimumab in metastatic melanoma
    Olischewsky, Alexandra
    De Schrijver, Sofie
    Bankfalvi, Agnes
    Wetter, Axel
    Zimmer, Lisa
    Livingstone, Elisabeth
    Schadendorf, Dirk
    Ugurel, Selma
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 95 : 104 - 108
12345